126 related articles for article (PubMed ID: 11369842)
1. Prevalence of cardiovascular damage in early renal disease.
Levin A
Nephrol Dial Transplant; 2001; 16 Suppl 2():7-11. PubMed ID: 11369842
[TBL] [Abstract][Full Text] [Related]
2. The beneficial effects of intervention in early renal disease.
Portolés J
Nephrol Dial Transplant; 2001; 16 Suppl 2():12-5. PubMed ID: 11369843
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of cardiovascular damage in the early renal population.
London G
Nephrol Dial Transplant; 2001; 16 Suppl 2():3-6. PubMed ID: 11369841
[TBL] [Abstract][Full Text] [Related]
4. The CREATE trial--building the evidence.
Eckardt KU;
Nephrol Dial Transplant; 2001; 16 Suppl 2():16-8. PubMed ID: 11369844
[TBL] [Abstract][Full Text] [Related]
5. [Improvement of left ventricular hypertrophy by anemic-correcting erythropoietin therapy in chronic renal insufficiency].
Jiang JP; Hou FF; Gao LZ; Pan YB; Yang NS; Chen W; Shu GY; Chen YM; Chen J; Peng WH; Wu JP; Yang ZM
Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):25-9. PubMed ID: 15769393
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin.
Levin A; Thompson CR; Ethier J; Carlisle EJ; Tobe S; Mendelssohn D; Burgess E; Jindal K; Barrett B; Singer J; Djurdjev O
Am J Kidney Dis; 1999 Jul; 34(1):125-34. PubMed ID: 10401026
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure.
Tucker B; Fabbian F; Giles M; Thuraisingham RC; Raine AE; Baker LR
Nephrol Dial Transplant; 1997 Apr; 12(4):724-8. PubMed ID: 9141001
[TBL] [Abstract][Full Text] [Related]
8. Relationship between different blood pressure measurements and left ventricular mass by cardiac magnetic resonance imaging in end-stage renal disease.
Merchant A; Wald R; Goldstein MB; Yuen D; Kirpalani A; Dacouris N; Ray JG; Kiaii M; Leipsic J; Kotha V; Deva D; Yan AT
J Am Soc Hypertens; 2015 Apr; 9(4):275-84. PubMed ID: 25753299
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of anaemia: focus on the heart and blood vessels.
Metivier F; Marchais SJ; Guerin AP; Pannier B; London GM
Nephrol Dial Transplant; 2000; 15 Suppl 3():14-8. PubMed ID: 11032352
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia.
Thanakitcharu P; Siriwiwatanakul N
J Med Assoc Thai; 2007 Dec; 90(12):2574-86. PubMed ID: 18386706
[TBL] [Abstract][Full Text] [Related]
11. Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL.
Ayus JC; Go AS; Valderrabano F; Verde E; de Vinuesa SG; Achinger SG; Lorenzo V; Arieff AI; Luño J;
Kidney Int; 2005 Aug; 68(2):788-95. PubMed ID: 16014057
[TBL] [Abstract][Full Text] [Related]
12. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.
Kim ED; Sozio SM; Estrella MM; Jaar BG; Shafi T; Meoni LA; Kao WH; Lima JA; Parekh RS
BMC Nephrol; 2015 Aug; 16():131. PubMed ID: 26249016
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and patterns of left ventricular hypertrophy in patients with predialysis chronic renal failure.
Ha SK; Park HS; Kim SJ; Park CH; Kim DS; Kim HS
J Korean Med Sci; 1998 Oct; 13(5):488-94. PubMed ID: 9811177
[TBL] [Abstract][Full Text] [Related]
14. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis.
Chan CT; Floras JS; Miller JA; Richardson RM; Pierratos A
Kidney Int; 2002 Jun; 61(6):2235-9. PubMed ID: 12028465
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in mediators of left ventricular hypertrophy in dialysis patients.
Savage T; Giles M; Tomson CV; Raine AE
Clin Nephrol; 1998 Feb; 49(2):107-12. PubMed ID: 9524781
[TBL] [Abstract][Full Text] [Related]
16. Anaemia, renal insufficiency and cardiovascular outcome.
Hegarty J; Foley RN
Nephrol Dial Transplant; 2001; 16 Suppl 1():102-4. PubMed ID: 11369834
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease in patients with chronic kidney disease.
Jaradat MI; Molitoris BA
Semin Nephrol; 2002 Nov; 22(6):459-73. PubMed ID: 12430090
[TBL] [Abstract][Full Text] [Related]
18. Managing a fateful alliance: anaemia and cardiovascular outcomes.
Eckardt KU
Nephrol Dial Transplant; 2005 Jun; 20 Suppl 6():vi16-20. PubMed ID: 15958821
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and predictors of the sub-target Hb level in children on dialysis.
van Stralen KJ; Krischock L; Schaefer F; Verrina E; Groothoff JW; Evans J; Heaf J; Ivanov D; Kostic M; Maringhini S; Podracká L; Printza N; Pundziene B; Reusz GS; Vondrak K; Jager KJ; Tizard EJ;
Nephrol Dial Transplant; 2012 Oct; 27(10):3950-7. PubMed ID: 22740719
[TBL] [Abstract][Full Text] [Related]
20. Contribution of anemia and hypertension to left ventricular hypertrophy during the initial 2 years after renal transplantation.
Ibernon M; Moreso F; Ruiz-Majoral A; Sarrias X; Sarrias M; Grinyó JM; Serón D
Transplant Proc; 2011; 43(6):2199-204. PubMed ID: 21839233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
